eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Phase III trial of dasatinib in patients with recurrent glioblastoma multiforme

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
  3. Resource Description
    Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well dasatinib works in treating patients with recurrent glioblastoma multiforme or gliosarcoma.
  4. Contact
    Berenberg, Jeffrey
  5. PI
    Berenberg, Jeffrey
  6. Topic
    glioblastoma multiforme
  7. Study Population
    Men and women 18 years of age or older with biopsy-proven supratentorial glioblastoma multiforme within 4 weeks of registration, and meeting other disease and treatment-related criteria.
  8. Funded by
    Radiation Therapy Oncology Group
  9. Phase
    Phase 2 clinical trial
  10. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016